All In Biotech

Free tool

FAERS Monitor: Vaseretic

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019221 or its brand name (Vaseretic, Enalapril Maleate, Hydrochlorothiazide). Reports on generic versions are filed under their own applications.

Reports

912

Serious

787

86% of reports

Hospitalization

507

Death reported

61

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug interaction58
  • diarrhoea54
  • nausea48
  • fall45
  • renal failure acute44
  • dizziness38
  • vomiting36
  • hypotension35
  • hyponatraemia34
  • renal failure34
  • dyspnoea32
  • drug ineffective31
  • fatigue30
  • headache29
  • hypertension29

Reports by year received

View as table
YearReports
200473
200579
200667
200742
200873
200972
201085
2011120
201290
201311
201422
201517
201619
201713
201836
201924
202031
202113
20225
20239
20244
20256
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,247 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
renal failure acuteSignal4423.917.9946
hyponatraemiaSignal3413.910.0396
drug interactionSignal588.46.6375
renal failureSignal345.94.2135
hypotensionSignal354.02.977
hypertensionSignal293.22.241
fallSignal453.12.364
diarrhoea541.91.524
vomiting361.81.311
dizziness381.81.312
nausea481.41.15
dyspnoea321.30.92
headache291.10.70
fatigue300.90.60
drug ineffective310.50.412

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.